All posts by imreal

Senior payments and software executive, Trevor Rubel, joins leading message-based-payments firm


News Image

“Authvia’s solutions are perfectly designed for the future and I’m looking forward to doing my part to help the company accelerate growth and expand its impact in the rapidly emerging world of conversational commerce,” Trevor Rubel, Authvia president and COO said.

Authvia, the maker of conversational commerce technologies that enable instant payment authorization via any payment processor, over any digital communication channel such as text, social media, chat, email, and messenger, announced the appointment of Trevor Rubel to the newly formed position of president and chief operating officer. In the role, Rubel will oversee the company’s global payment partnerships, business operations, and lead the application programming interface (API) partner channel rollout that is currently underway.

“Authvia is in the midst of exciting growth and now is the time to add demonstrated leadership, as well as proven experience in scaling, developing and shaping an organization for the future,” said Chris Brunner, Founder and CEO of Authvia. “Trevor brings all of that and more with a customer-first mindset that fits perfectly with our culture here. I’ve had the opportunity to work with him over the last few years as the CEO of Merchant e-Solutions and know that he’ll add tremendous value to the business and the organization as we write our next chapter.”

Rubel brings an unrivaled view of the payments/software ecosystem to Authvia, including hands-on experience launching and scaling new products in the payments space. In addition to his most recent role as co-CEO at Merchant e-Solutions, Rubel spent over 10 years as a senior executive at Bank of America Merchant Services and First Data. Rubel’s experience also includes driving innovation, product, operations, and corporate development at emerging technology companies, including Intelligent Results, Personify, and CareCap. His track record includes growing early stage startups through acquisition, as well as bringing enterprise-level products to market.

“I’m seeing a fundamental transformation in the industry as payments are increasingly embedded into business software solutions and consumers are looking for easier payment methods that support a contactless experience,” Rubel said. “Authvia’s solutions are perfectly designed for the future and I’m looking forward to doing my part to help the company accelerate growth and expand its impact in the rapidly emerging world of conversational commerce.”

About Authvia:

Authvia is a Los Angeles-based technology firm offering patent-pending applications and a frictionless, API-driven platform that facilitates contactless, secure, and fast payment acceptance via popular messaging platforms such as Text, SMS, social media, and chat. Authvia APIs connect out-of-box to 20+ payment processors and gateways, are easily integrated into any business management software solution, and accelerate merchant cash flow using digital engagement to streamline on-demand payment and receivables, all while remaining completely contactless.

Share article on social media or email:

Americans have little trust in what President Trump says regarding COVID-19 or his management of the pandemic


FDU School of Pharmacy and Health Sciences logo

FDU School of Pharmacy and Health Sciences logo

“The findings point to the immense level of distrust Americans have in the ability of elected officials to communicate information needed to manage the COVID-19 pandemic,” said Bojana Beric-Stojsic, MPH program and an Associate Professor of Public Health, FDU School of Pharmacy and Health Sciences.

Americans are getting information about the coronavirus pandemic from political leaders and medical professionals, but confidence in those sources varies widely. A recent national survey conducted on behalf of the Fairleigh Dickinson University School of Pharmacy and Health Sciences finds that Americans are more likely to trust information that comes from medical professionals than politicians, with President Trump seen as least trustworthy regarding the information he provides. This and other findings from the survey suggest that Americans are putting their faith in medical expertise when it comes to getting critical information on how to best protect themselves and their loved ones from COVID-19. There are, however, substantial differences in who and what they trust based on a person’s politics and race.

The poll interviewed 1003 American adults nationwide on landlines and cell phones from May 20 through May 25, 2020.

Medical professionals top the list of those Americans say they trust most for information about the coronavirus. Fifty-eight percent say they have a “great deal” of trust in doctors and scientists, while government run websites are trusted by around a third of all Americans (36%). However, once political leaders become the source of information, Americans are more likely to distrust than trust what they see, hear, or read. Around a quarter (27%) have a great deal of trust in statewide elected officials, including their governor, and barely a fifth (22%) fully believe what their president tells them. In fact, the president is the only source who a majority (55%) of Americans distrust rather than trust.

“These findings point to the immense level of distrust Americans have in the ability of elected officials to communicate critical information needed to manage the COVID-19 pandemic and the obvious lack of meaningful leadership at the federal level,” said Bojana Beric-Stojsic, director of MPH program and an Associate Professor of Public Health, FDU School of Pharmacy and Health Sciences. “What is most surprising and very distressing is that only 58 percent of Americans have a great deal of trust in doctors and scientists in the midst of a health crisis.”

Americans do give doctors and scientists much higher marks than the president when it comes to evaluating the reasons for evolving and sometimes conflicting information. Almost eight-in-ten believe that doctors and scientists change their recommendations on how to prevent and treat the coronavirus based on newly discovered scientific evidence (77%) rather than bowing to political pressure (23%). The opposite is true when it comes to the president, as more than half (53%) say his recommendations often change for political reasons rather than newly emerging scientific evidence (47%).

There is, however, a significant partisan divide on these issues. Although clear majorities of both Democrats and Republicans say that changing recommendations from doctors and scientists are due to newly discovered scientific evidence, President Trump’s evolving statements are understood very differently. Eighty-four percent of Republicans believe science dictates the president’s statements, while virtually the same percentage of Democrats (86%) believe political pressures explain changes in President Trump’s public statements about how to prevent and treat COVID-19. A huge gap between Democrats and Republicans also characterizes perceptions of the overall trustworthiness of the president (3% versus 47%), with a smaller but still significant difference separating Democrats from Republicans on their willingness to extend a “great deal” of trust to statewide elected officials like the governor (36% versus 20%).

“It’s notable that not even among his own partisans and those who approve of the job he’s done in managing this crisis does the President get a majority to say the information he provides about the coronavirus can be trusted a great deal,” said Krista Jenkins, director of the FDU Poll and professor of government and politics.

There are also significant racial disparities in assessing Trump’s performance and trustworthiness. More black Americans (83%) disapprove of the President’s management of the pandemic compared to 43 percent of white and 62 percent of Hispanic respondents; and 70 percent of blacks have absolutely no trust that the President provides accurate information about the coronavirus, compared to 37 percent of whites and 44 percent of Hispanics. More black Americans (79%) also believe Trump changes his recommendations about the coronavirus due to political pressure compared to 47 percent of whites and 60 percent of Hispanics.

“Minorities have been hit hard by the virus. Navigating their way through this pandemic is apparently being made more difficult by the deep well of distrust that exists between President Trump and non-whites in the United States. These numbers only serve to underscore how black, white and Hispanic Americans experience life differently in the United States, even on matters of life and death,” said Jenkins.

When it comes to how medical and science professionals are perceived, partisanship also comes into play, with Republicans expressing greater levels of suspicion than Democrats. Three-quarters of Democrats say they trust doctors and scientists a great deal to provide them with solid information about the coronavirus. Significantly fewer Republicans say the same (43%). And a double digit divide separates partisans on the trustworthiness of information from government run websites, such as the Centers for Disease Control and Prevention (CDC) (49% Democrats versus 24% Republicans).

Gender also reveals differences in how sources are regarded. Significant disparities exist between how much men and women trust websites like the CDC’s. Forty-two percent of women have a great deal of trust in what they read versus 29% of men. And, although majorities of both women and men give high marks to doctors and scientists for what they offer, women (63%) are more likely than men (54%) to do so.

Governors Trump Trump on Leadership

Governors are rated higher than President Trump on questions of leadership during the crisis. Sixty-nine percent approve of their governor’s job, with opinion divided on the job that the president has done (49%). The performance of state governors is regarded similarly by partisans of both stripes, but the President gets little love from Democrats (11% approve; 89% disapprove), and only about half of political independents say he’s doing a good job (48%).

State leaders generate mixed opinions among Americans who live somewhere with past or present mandatory restrictions on where they can go and what they can do. Among the 90 percent of Americans surveyed who live somewhere with mandatory restrictions, around half (46%) say their state has moved safely to reopen, with a greater number believing things have moved too quickly (31%) as compared with those who are concerned the pace has been too slow (23%). However, black respondents are even more critical of reopening efforts, as 51% of black respondents say states are reopening too quickly, compared to 26% of whites and 41% of Hispanics.

Finally, Americans give their neighbors high marks for the job they’ve done in helping the stop the spread of the virus. Around a quarter (22%) say those in their community are doing an “excellent” job with another 46 percent who give those around them a “good” rating. The rest rate their neighbors as “only fair” or “poor” when it comes to their efforts in stopping the spread of the virus and flattening the curve.

Methodology

The survey was conducted by The Fairleigh Dickinson University Poll on behalf of the FDU School of Pharmacy and Health Sciences. A random sample of 1003 was drawn of adults (18+) nationwide, including in Alaska and Hawaii, and live interviews were conducted in English and Spanish, upon request, on landlines and cell phones between May 20 through May 25, 2020. Persons without a telephone could not be included in the random selection process. Respondents within a household are selected by asking randomly for the youngest adult currently available. The interview was conducted in English and included 303 adults reached on a landline phone and 700 adults reached on a cell phone, all acquired through random digit dialing.

In this poll, the simple sampling error for 1003 adults is +/-3.6 percentage points (including the design effect) at a 95 percent confidence interval. Thus, if 50 percent of adults nationwide in this sample favor a particular position, we would be 95 percent sure that the true figure is between 46.4 and 53.6 percent (50 +/- 3.6) if all US adults had been interviewed, rather than just a sample.

The full analysis, along with the poll’s questions and tables and a detailed methodological statement, can be found on the FDU Poll website.

About Fairleigh Dickinson University

Devoted to the preparation of world citizens, Fairleigh Dickinson University offers over 100 undergraduate and graduate degree programs, including doctoral programs in pharmacy, nursing practice, clinical psychology and school psychology; and an AACSB-accredited business school. Degree programs are offered on two New Jersey campuses and at two international campuses: Wroxton College, in Oxfordshire in England, and the Vancouver Campus, in British Columbia, Canada. For more information, visit here

About FDU Poll

The FDU Poll is a university based survey research center that began in 2001. It has conducted over a hundred publicly released polls guided by a mission to provide high quality, scientifically sound, non-partisan measures of important issues facing New Jersey and the nation. To learn more visit us online

About FDU’s School of Pharmacy & Health Sciences

The Fairleigh Dickinson University School of Pharmacy & Health Sciences is one of only two degree-granting pharmacy schools in New Jersey, and is the first in the state to be associated with a private university. The School’s dynamic program of study integrates the very best practices in pharmacy education today. The school has also expanded its presence in the field of public health and health professions with the addition of health sciences programs such as Master of Public Health, Master of Social Work, Occupational Therapy and Physician Assistant.

MIPI Alliance Recognizes Members at Annual Awards Ceremony


The MIPI Alliance, an international organization that develops interface specifications for mobile and mobile-influenced industries, today announced the 2019 MIPI Alliance Membership Award recipients. The awards were presented at a virtual State of the Alliance and Awards Ceremony.

“The MIPI annual awards program follows a tradition of recognizing individuals and companies whose dedication and contributions have made notable impacts in the development of specifications that advance hardware and software integration in mobile, IoT, automotive and other areas,” said Joel Huloux, chairman of MIPI Alliance. “MIPI greatly values its entire membership, and it’s rewarding to see firsthand the camaraderie and respect shared throughout the organization as we recognize key contributors to MIPI’s important specification development work.”

The annual awards program recognizes outstanding contributions and achievements by individual and corporate members. An awards and recognition committee appointed by the board of directors receives nominations from MIPI members and selects the recipients. This year’s program honored six award recipients in four categories: Lifetime Achievement, Working Group Leadership, Distinguished Service and Corporate.

The Lifetime Achievement Award is presented to individuals who have participated in MIPI Alliance efforts for at least seven years and provided significant contributions or leadership to a working group, the board or other MIPI entities. Two individuals were awarded this year: Roy Chestnut of Teledyne LeCroy and Tom Kopet of ON Semiconductor.


  • As chair and vice chair of the MIPI DevCon Steering Committee since the inaugural DevCon event, Roy Chestnut has played an instrumental role in providing developer resources and promoting MIPI’s overall value to the industries it serves. Throughout his years of service, and continuing today, he has demonstrated notable dedication to MIPI and made valuable contributions to the committees and working groups in which he participates.
  • With over 15 years of service, Tom Kopet has been a long-standing technical contributor. As the current vice chair of the MIPI Camera Working Group, he has worked extensively to promote consistency across different MIPI specifications and was recognized for his invaluable contributions to the MIPI CSI-2 specification.


The Working Group Leadership Award is presented to leaders within MIPI working groups in recognition of noteworthy contributions to the groups’ activities or specification development work. Two individuals were recognized for their efforts this year:

  • Haran Thanigasalam of Intel Corporation was recognized for his devoted work as chair of the MIPI Camera Working Group, playing the lead role in delivering a robust camera and imaging interface roadmap. His notable contributions include the advancement and expanded adoption of MIPI CSI-2, evolving it as the de facto specification for multiple product platforms for the mobile, PC, IoT and automotive industries.
  • Enrico Carrieri of Intel Corporation was awarded for his leadership as chair of the MIPI Debug Working Group. He was cited for his broad technical knowledge and organizational skills within and across MIPI working groups, demonstrating how closely interdependent specifications can be developed in parallel.


The Distinguished Service Award recognizes individuals impacting the MIPI specification development process or those contributing by serving on the board of directors, a working group or helping in the areas of marketing and testing. Eyuel Zewdu Teferi of STMicroelectronics was awarded for multiple contributions to advance the development and adoption of the MIPI I3C and I3C Basic specifications. He was also recognized for his efforts to support collateral MIPI activities, including acting as a liaison to JEDEC, contributing to the MIPI I3C Conformance Test Suite currently under development and participating in interoperability sessions, while also staying abreast of emerging security issues.

The Corporate Award was presented to Samsung Electronics, Co., an active member of MIPI Alliance since joining in 2004. Samsung was honored for its leadership on the board of directors, as well as the Marketing Steering Group and Display Working Group. Participating in virtually every MIPI working group and having made significant contributions to MIPI CSI-2, C-PHY, DSI-2, UniPro and, in particular, D-PHY, the company was recognized for its ongoing proactivity and commitment to the Alliance. The company continues to support not only specification and resource development but also key efforts such as MIPI DevCon Seoul to help advance the adoption and enablement of MIPI specifications.

Also honored in memoriam during the ceremony were two individuals who made indelible contributions to MIPI Alliance:

  • Dr. Thomas Marik, co-founder and former CTO of BitifEye Digital Test Solutions GmbH, was a key developer of MIPI testing methodologies and resources, as well as a significant contributor to the evolution and progression of MIPI’s physical layer specifications. Dr. Marik served as BitifEye’s primary MIPI representative from 2008 until his death in 2018.
  • Paul Vishny, MIPI Alliance’s founding legal counsel, played an instrumental role in helping to establish and structure the organization for enduring success. For his efforts, Vishny was awarded the MIPI Lifetime Achievement Award in 2016. He passed away in April 2020.


Photos and information about past recipients may be found here: https://www.mipi.org/membership/annual-awards

To discover more about MIPI Alliance, subscribe to its blog and connect with its social networks by following MIPI on Twitter, LinkedIn and Facebook.

About MIPI Alliance

MIPI Alliance (MIPI) develops interface specifications for mobile and mobile-influenced industries. There is at least one MIPI specification in every smartphone manufactured today. Founded in 2003, the organization has over 325 member companies worldwide and 14 active working groups delivering specifications within the mobile ecosystem. Members of the organization include handset manufacturers, device OEMs, software providers, semiconductor companies, application processor developers, IP tool providers, automotive OEMs and Tier 1 suppliers, and test and test equipment companies, as well as camera, tablet and laptop manufacturers. For more information, please visit http://www.mipi.org.

MIPI®, MIPI I3C® and MIPI UniPro® are registered trademarks owned by MIPI Alliance. MIPI C-PHY℠ CSI-2, MIPI D-PHY℠, MIPI DSI-2℠ and MIPI I3C Basic℠ are service marks of MIPI Alliance.

###

Press Contact:

Lisa McCausland

Interprose for MIPI Alliance

+1 303.888.2137

lisa.mccausland@interprosepr.com

Share article on social media or email:



The Best WLAN in noax Logistics Computers for Industrial Vehicles & Forklifts


noax compact 12" industrial computer with integrated WLAN mounted in a forklift and in use at a HUK-Coburg warehouse.

noax C12 industrial PC with integrated WLAN in action at HUK-Coburg

The excellent transmission capabilities and optimized design result in better connectivity and reduced loss of data.

noax logistics terminals offer the highest security in data transfer and very wide coverage in support of current WLAN standards. The new internal WLAN antennas on the logistics PCs provide excellent reception capabilities and are designed specifically for mobile use.

Best WLAN – Maximum Reception

Continuous uninterrupted data transfer is essential for smooth operations in warehouses and logistics. Stellar WLAN reception on the logistics terminals is critical when it comes to equipping a fleet of industrial vehicles. Depending on the WLAN coverage and application, noax logistics touchscreen computers can be equipped with integrated or external antennas. This allows the PC’s to perfectly adapt to the respective infrastructure. The logistics industrial PCs support both frequency bands: 2.4 GHz or 5 GHz.

Perfect Roaming – Optimized Network Connectivity

Two common problems when moving between WLAN (Wifi) access points are intermittent connectivity and loss of data. noax counteracts these performance limitations with the use of improved connectivity components and specific positioning of integrated antennas (external antennas are available). The noax logistics terminal has several options to adjust the internal wireless settings to improve connectivity. The excellent transmission capabilities and optimized design result in better connectivity and reduced loss of data.

Greatest flexibility – Cellular and WiFi

WLAN coverage may not be available everywhere, especially on large company campuses. For very large campuses where complete coverage with WLAN is not possible, noax logistics terminals can be equipped with a mobile phone card and suitable antennas. The ability to utilize cellular networks guarantees mobility and data availability.

Tried and tested in practical applications

These features ensure extremely reliable mobile applications for noax logistics terminals. This is critical where continuous and uninterrupted data transfer is essential.

In the high-bay warehouse at HUK-COBURG Insurance Group, the stable WLAN on the noax logistics computer ensures continuous data streaming. Due to considerable interruptions with WLAN in the existing inventory of vehicle computers, HUK-COBURG opted for noax industrial PCs because of their powerful WLAN reception. HUK-Coburg uses the logistics terminals with external antennas for the high-reach forklifts because they are specifically designed for areas with poor coverage. The new vehicle computers have internal antennas that reliably operate, even in areas with poor coverage.

About noax Technologies Corporation

noax Technologies Corp. ranks among the world’s leading manufacturers of high-end, rugged and reliable industrial PCs. The company has over 25 years of experience in developing and producing completely sealed systems. noax also offers a full spectrum of services ranging from consultation and sales to installation and comprehensive support. noax industrial PCs are used all over the world in the most demanding industrial environments at well-known companies in the automotive, logistics, food processing, and chemical industries, amongst others. These computers were developed specifically for industrial use and prove their resistance to heat, cold, moisture, dust, vibration, and shock on a daily basis.

Reproduction permitted. Please send us a copy. Feel free to contact us if you have questions.

http://www.noax.com

Share article on social media or email:

Exploring Changes of Myeloid Cells with Chromogenic Multiplex IHC in Advanced Liver Cancer, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

Multiplex immunohistochemistry is the best suitable technology, allowing spatial detection and quantification of complex immune cell phenotypes.

Join Nagy Habib, Professor of Surgery, Imperial College London; Co-Founder, MiNA Therapeutics and Jacques Fieschi, PhD, VP of R&D, HalioDx in a live webinar on Monday, June 8, 2020 at 11am EDT (4pm BST/UK).

Assessing the tumor microenvironment has proved to be immensely informative in the context of clinical trials. Multiplex immunohistochemistry is the best suitable technology, allowing spatial detection and quantification of complex immune cell phenotypes.

Thanks to the unique HalioDx’ Brightplex® technology, pharma companies can access customized panels, providing valuable data and insights to further understand the mechanism of action of their drugs.

MTL-CEBPA is a small activating RNA therapeutic (saRNA) which, when combined with sorafenib, induces a novel myeloid differentiation in patients with advanced hepatocellular carcinoma (HCC).

HalioDx has specifically developed 3 Brightplex® panels, containing up to seven biomarkers each, for the identification and the quantification of different myeloid cells such as myeloid derived suppressor cells (MDSCs), neutrophils (N1/N2) and M1 and M2 macrophages on treated patient samples.

This technology, which uses one FFPE slide per panel, was rolled out to explore these changes by comparing pre- and post-treated samples from patients who have received MTL-CEBPA in combination with sorafenib during a Phase I a/b of a clinical trial study.

For more information or to register for this event, visit Exploring Changes of Myeloid Cells with Chromogenic Multiplex IHC in Advanced Liver Cancer.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

White Hires Adam Kraft as National Sales Director for Retail


News Image

White, a global leader in end-to-end solutions for automated packaging, intelligent storage, and storage automation software, announced today that Adam Kraft has joined the company as the National Sales Director for Retail. Kraft will lead White’s expansion into the retail pick-up market, which is undergoing significant growth due to the increase of online ordering during the Covid-19 pandemic.

“Adam brings a wealth of experience to these unprecedented times, when many consumers have ordered online and picked up in store or curbside for the first time. In the future, many customers will continue to buy online. Buy online pick-up in store was growing prior to Covid-19, but it has now surged in popularity. Stores are trying to find ways to manage online orders and we are excited to have Adam to ensure their success in automation,” Corey Calla, President of White, said.

Kraft, a licensed healthcare professional, has more than 16 years of experience in medical sales, including pharmaceutical, implantable device, and medical technology integration. His extensive knowledge of the healthcare and medical sales industry spans from the consumer to the patient and through to healthcare systems, and this expertise will enable White to work with retailers to design tailored storage and software solutions that enhance not only their product delivery models, but also the customer experience.

“I am truly excited to join the team at White,” Kraft said. “This organization is uniquely positioned to bring customer-centric solutions to a rapidly evolving market of improved e-commerce delivery and workforce efficiency. Retailers will need to continue to adapt to stay competitive. White is the perfect trusted partner to bring innovative solutions and value through service to each of these businesses.”

White is a provider of high-density storage and retrieval solutions and software for e-commerce, hospital pharmacies, manufacturing, distribution and fulfillment, aerospace, in-store pickup and military point-of-use solutions. Recently, some retail segments, such as grocery, have seen more than a 200% increase in online ordering.

About SencorpWhite:

SencorpWhite is a leading provider of unique end-to-end solutions for the packaging and management of high-value inventory. White, a business unit of SencorpWhite, is a market leader in innovative intelligent storage solutions and software systems. The company’s products and services– which range from White automated storage and retrieval systems, Sencorp thermoformers, CeraTek and Accu-Seal heat sealers, and Intek and Minerva item management software– cover the entire supply chain, from the point-of-manufacture through distribution and to the point-of-use. For more information, call (508) 771-9400 or e-mail info@sencorpwhite.com.

Follow Us

https://www.linkedin.com/company/sencorpwhite

https://twitter.com/sencorpwhite

https://www.facebook.com/SencorpWhite-1592452881046361/

https://www.instagram.com/sencorpwhite/

https://www.youtube.com/channel/UCKITGVQlcBaKCFjX_QkujPg

Share article on social media or email:



ClearVu School Services Announces Expansive Services to Assist K-12 School Nutrition Programs


News Image

“At ClearVu we eliminate these worries, we bring transparency and deliver significant savings with no out-of-pocket expense,” stated Mr. Meyers

ClearVu School Services, a leader in group purchasing and supply services to support K-12 school nutritional programs, announces their unique approach to provide transparency and increase savings for school foodservice programs.

ClearVu School Services offers the largest group purchasing portfolio in the industry. With $22 billion in combine annual purchases and over 98,000 food and supply products. The group purchasing leverage with the manufacturing community provides immediate savings to school districts without interfering with existing distributor bids and meets USDA procurement regulations.

Accepted by over 1800 hundred distributors utilizing 350 brand name manufacturers, the group purchase portfolio has many of the products currently purchased by school foodservice programs. The portfolio is particularly effective in covering many of the off-bid purchases brought on by the Coronavirus.

Unlike other providers of group purchasing programs with rebates – ClearVu is completely transparent. Rebates are paid monthly with reporting of all financial information down to the invoice item level. Typical savings are 1-3% with no change to existing purchases practices.

“The biggest benefit with ClearVu is our knowledge of federal, state and local purchase regulations and management of USDA donated food programs,” says Cliff Meyers, President of ClearVu. “Our programs meet procurement regulations and we support our members with regulatory audits”.

ClearVu also offers support with micro purchases, informal purchases, invitations for bid, requests for proposals, Buy American initiatives, donated food further processing, multi-year contracting and audit compliance.

School foodservice procurement has been ignored by many group purchasing providers due to the lack of understanding or misunderstanding of governmental regulations. “At ClearVu we eliminate these worries, we bring transparency and deliver significant savings with no out-of-pocket expense,” stated Mr. Meyers. The global Coronavirus is causing major change to school nutritional programs, ClearVu is the only provider that can effectively assist schools in navigating these changes while reducing costs.

About ClearVu:

ClearVu School Services was founded on a simple premise. Busy school nutrition directors do not have the time and resources to keep up with governmental regulations, efficiently procure food and supplies, manage supplier relationships, cost, and rebates, while staying abreast of continuous changes in the market. ClearVu with their unmatched expertise, provides a way to handle those details while saving money. A lot of money.

In fact, our group purchasing power exceeds $22 billion. That leverage combined with distribution and industry expertise has enabled us to provide a safe and unmatched school foodservice purchasing support. Maximizing manufacturer rebates, reducing invoice costs, and providing up-to-date market and product insight. We guarantee we will outperform any other service provider.

Share article on social media or email:

AX Semantics Launches Content Generation Software for Pharmaceutical Sector


AX Semantics, the easiest way to automate your content production

Content automation driven by NLG technology connects to the clinical study database and instantly generates HIPAA-compliant, auditable reports that help pharmaceutical companies meet regulatory requirements at a time when getting the right medications approved quickly is critical to global health.”

AX Semantics, an AI-powered, Natural Language Generation (NLG) market leader, today announced a new range of HIPAA-compliant content generation software for the pharmaceutical sector, which will allow pharmaceutical companies to generate regulatory Clinical Study Reports (CSRs) on medications up to 40% faster by automating 30% of writing the CSR.

“In addition to its effect on human lives and the economy, the coronavirus pandemic has exposed the hurdles pharmaceutical companies must overcome to get medication to patients. These processes are doubtless important to keep medications safe, but they also rely on outdated processes,“ said Saim Rolf Alkan, CEO and founder of AX Semantics. “Content automation driven by NLG technology connects to the clinical study database and instantly generates HIPAA-compliant, auditable reports that help pharmaceutical companies meet regulatory requirements at a time when getting the right medications and vaccines approved as expeditiously as possible is critical to ensure global public health.”

AX Semantics Upends the Status Quo.

The most challenging phase of bringing a drug to market is the human drug trial, or Phase III, during which time clinicians must write a CSR that describes the pharmacological impacts and trial outcomes. Typically, data collected from the human drug trials is gathered and medical writing teams manually compile the report, however, this outdated, onerous and time-consuming process can potentially delay life-saving medications from coming to market sooner and cost pharmaceutical companies millions. A capacity challenge also exists. Writing a CSR report typically takes several months to complete, which limits the number of CSRs a team of medical writers can produce annually. Some pharmaceutical companies have tried using templates to overcome the manual writing process challenge, however the templates have been found to be too complex and rigid for the different scenarios the CSR encompasses. For example, acceptable mortality rates can differ significantly depending on the drug that is being trialed: a drug that treats late stage cancer may have a mortality rate of 8%, which is acceptable, but a rate that high for a drug that treats a migraine headache is completely unacceptable. Templates cannot deal with these types of different scenarios, which severely limits their value.

AX Semantics content generation features for pharmaceutical and clinical study reports, include:

  • NLG output based on structured data: allows users to easily configure projects to any structure and import tools and formats including JSON, CSV and Excel, and API for integration into existing systems like Oracle Databases without the need for complex IT projects;
  • Topic and domain independent technology: all types of text can be generated, not just a limited set of topics — in up to 110 different languages;
  • Easy-to-use interface with real-time, multi-user capability and workflows: multiple people can work on a project at the same time, allowing scaled project sizes, while retaining the ability to test and deploy; and
  • Data Protection and Hybrid Cloud Availability: with certifiable processes and infrastructure that can be used for confidential information up to HIPAA/PHI level, and Sarbanes–Oxley/MARisk certifiable processes.

Named one of the world’s top five providers of natural language generation platforms by Gartner, and a top emerging company in the NLG market by Forrester, AX Semantics offers a subscription-based service, with fees between $279 and $1699 per month for pharmaceutical companies. A managed service that creates the CSR reporting is also available on top of the self-service platform for new product development purposes and customers that don’t have qualified in-house resources by utilizing the global Network of AX Semantics’ Managed Service Providers like hmmh (Serviceplan Group), Deloitte and uNaice. An industry first, this fully managed project is available at fixed flat rates with a pricing from $7,999 to $18,999, further reducing ramp up time for the project and minimizing the needed investments. The software is 100% SaaS – everything is available via a web browser, with no programming or IT departments required. Self-service with integrated e-learning allows customers to start automating text within 48 hours, often less. Learn more at sales@ax-semantics.com.

About AX Semantics

AX Semantics is an AI-powered, natural language generation (NLG) software company built to address today’s biggest content generation challenges. Our sophisticated SaaS-based solution effortlessly creates vast quantities of content at scale – to tackle time-intensive financial reporting and regulatory requirements filings, automate laborious pharmaceutical Clinical Study Reports, fill a news section with earnings reports, sports scores or weather reports, generate 1000s of unique product descriptions for e-commerce brands, produce social media content, and more. We make automated content generation — in more than 110 languages, in a manner of minutes — a reality for customers of all sizes within the finance, pharmaceutical, e-commerce, business and media publishing sectors.

Headquartered in Stuttgart, Germany with an additional office in Sunnyvale, California, AX Semantics is a privately-held company backed by Airbridge Equity Partners. Follow us on social at Twitter, LinkedIn, Facebook and Instagram, or learn more at https://en.ax-semantics.com.

All trademarks contained herein are the property of their respective owners.

Share article on social media or email:



Periodontist Reopens Practices in Garden Grove and Diamond Bar, CA, Offers Life-Changing Treatment


Dr. Jin Kim, Periodontist in Garden Grove, CA

Dr. Jin Kim, Periodontist in Garden Grove, CA Reopens Periodontal Practice

Oral health is the cornerstone of overall health. If left untreated dental concerns can grow and become systemic issues.

Dual board-certified periodontist and international lecturer, Dr. Jin Kim, reopens his two periodontal practices in Garden Grove and Diamond Bar, CA with new safety measures in place. Closely adhering to recommendations by the Centers for Disease Control and Prevention (CDC), the American Dental Association (ADA), as well as the local and federal authorities, Dr. Kim and his staff have implemented new safety measures to protect their community’s health during the COVID-19 pandemic.

Oral health is the cornerstone of overall health. If left untreated dental concerns can grow and become systemic issues. Infection or inflammation in the gums, common signs of gum disease, can spread throughout the body and lead to chronic inflammation and a strained immune system. In order to preserve patients’ health and help them maintain an overall healthy life, Dr. Kim and his team welcome patients for gum disease treatment as well as dental implant services.

A specialist in gum disease treatment and dental implant surgery, Dr. Kim is also dual board certified by the American Board of Periodontology and the American Board of Oral Implantology/Implant Dentistry. In addition to his specialized periodontal training, Dr. Kim has advanced degrees in oral pathology, public health, and oral biology. Over his decades in practice he has seen first-hand the mouth-body connection and the improvements periodontal treatment can have on a patient’s life.

Offering minimally invasive care whenever possible, Dr. Kim and his team offer LANAP® laser gum therapy, an FDA-cleared solution to effectively treat gum disease with less discomfort and within fewer appointments. He also uses guided dental implant technology for precise and predictable dental implant placement for nearly 100 percent restored function. In fact, he can restore complete tooth loss in just one visit with All-on-4® full mouth dental implants.

Understanding the importance of complete oral health and a healthy immune system, now more than ever, Dr. Kim and his team are eager to welcome back their existing patients as well as any new patients in and around their area. Always adhering to the highest level of OSHA required Universal Safety Precautions, they have implemented additional safety guidelines for their patients’ comfort and health.

Among other measures, the staff will wear personal protection equipment (PPE) at all times when in contact with patients. Reducing the number of patients in the waiting room at one time, they are encouraging those who are able, to use their cars as their own personal waiting rooms. EPA-approved chemicals are used to sanitize each patient’s room after each visit. Each practice also receives a deep cleaning more frequently as well.

Dr. Kim and his team will closely monitor updates made by the CDC, ADA, and state and federal authorities amid the COVID-19 pandemic.

To learn more about the safety measures being taken by periodontist, Dr. Kim, or to schedule a consultation call 714-898-8757 for their Garden Grove practice or 909-860-9222 for their Diamond Bar location. To read more about the services this team offers including gum disease treatment and life-changing dental implant services, visit their website http://www.drjinkim.com.

About the Periodontist

Dr. Jin Kim is a periodontist dedicated to providing personalized dental care in Diamond Bar and Garden Grove, CA. Dr. Kim attended the University of Sydney Faculty of Dentistry before furthering his education with an advanced degree in pathology from the Medical School of the same University. Dr. Kim completed a periodontics and implant surgery residency at UCLA School of Dentistry and is board-certified by the American Board of Periodontology and the American Board of Oral Implantology/Implant Dentistry. He is a past president of the Western Society of Periodontology and was also inducted to be a Fellow of the prestigious American College of Dentists and earned Fellowships in the International Congress of Oral Implantologists and the American Academy of Implant Dentistry. Dr. Kim lectures and holds faculty positions at a number of universities including UCLA School of Dentistry and abroad. He has spoken at no less than 36 different countries across the globe as well as national and international academic and clinical associations and universities including the International Association of Dental Research, American Academy of Periodontology and Academy of Osseointegration. To learn more about Dr. Jin Kim and the services he offers, visit his website at http://www.drjinkim.com or call 909-860-9222 for the Diamond Bar location or 714-898-8757 for the West Garden Grove location to schedule an appointment.

Share article on social media or email:

Knowing Signs and Symptoms of Lyme Disease Is Critical for Early Detection and Treatment, Says Industry-Leading Quidel


News Image

Unlike a mosquito bite where people know immediately if they have been bitten, a tick bite may go undetected; and one of the challenges with Lyme disease is that symptoms may not appear for two to six weeks. That makes it critically important to take steps to avoid catching the disease and to know its warning signs so treatment can begin early when it is most effective.

“While not all deer ticks cause Lyme disease, it is still smart to avoid areas where deer ticks live, especially wooded, bushy areas with long grass,” said Sean McCloy, M.D., a family medicine physician with an expertise in Lyme disease at the Integrative Health Center of Maine. “You can decrease your risk of getting Lyme disease with some simple precautions, such as wearing shoes, long pants tucked into your socks, a long-sleeved shirt, a hat and gloves. And after spending time in vulnerable areas you should always check your clothing, yourself, your children and your pets for ticks; and remove any that you find as soon as possible with tweezers. Only a minority of tick bites leads to Lyme disease; but the longer the tick remains attached to your skin, the greater your risk of getting the disease.”

For those who are bitten by an infected tick, early warning signs include fever, headache, fatigue, joint pain, swollen lymph nodes, weakness in the limbs and a characteristic skin rash often in a bull’s-eye pattern. If untreated, new symptoms could include neurological problems and, though less common, heart problems (such as an irregular heartbeat), eye inflammation, liver inflammation and severe fatigue.

“If you think you’ve been bitten and have signs and symptoms of Lyme disease—particularly if you live in an area where Lyme disease is prevalent—it is critical to get tested as treatment is more effective if begun early,” said Robert Dracker, M.D., chairman of the heart, lung and cancer committee for the Medical Society of New York and medical director of Summerwood Pediatrics and Infusacare Medical Services in New York. “Fortunately, new tests are available that are easy to administer and provide results faster than ever.”

Leading the way in Lyme disease testing is the innovative Sofia 2 Lyme FIA test. This in-office test provides a patient as well as his or her physician with indicative results within minutes as opposed to days, which has historically been the norm. Performed in the privacy of a doctor’s office or local clinic, it is also the only test that can get results from a simple finger prick of blood. The test was developed by Quidel, a California-based diagnostic healthcare manufacturer and one of the nation’s leaders in developing rapid diagnostic health solutions.

“Given that the vast majority of patients tested are negative, getting results quickly will mean discernable peace of mind and remove a significant weight off a person’s shoulders,” said Dr. Dracker. “Not having to wait days for test results allows physicians and nurse practitioners to more rapidly treat those patients with positive results while more quickly pursuing other diagnosis and treatment for those who test negative.”

Patients seeking more information are encouraged to contact their private physician to find out more about the availability of this innovative new test in their area. More information on Quidel may be obtained at quidel.com.

About Quidel Corporation

Quidel Corporation serves to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. Quidel’s products aid in the detection and diagnosis of many critical diseases and conditions including not only Lyme disease but, among others, influenza, respiratory syncytial virus, strep A, herpes, pregnancy, thyroid disease and fecal occult blood. Quidel’s research and development engine is also developing a continuum of diagnostic solutions from advanced immunoassay to molecular diagnostic tests to further improve the quality of healthcare in physicians’ offices and hospital and reference laboratories. For more information about Quidel, visit quidel.com.

Share article on social media or email: